Selected research
Market Structure
Global Menopausal Hot Flashes Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Menopausal Hot Flashes Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Menopausal Hot Flashes Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Menopausal Hot Flashes Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Menopausal Hot Flashes Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Menopausal Hot Flashes Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Menopausal Hot Flashes Drugs include Novartis, Pfizer, Bayer, Novo Nordisk, iHealth Labs, Hisamitsu Pharmaceutical and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Menopausal Hot Flashes Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Menopausal Hot Flashes Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Menopausal Hot Flashes Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Menopausal Hot Flashes Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Menopausal Hot Flashes Drugs Segment by Company
Novartis
Pfizer
Bayer
Novo Nordisk
iHealth Labs
Hisamitsu Pharmaceutical
Allergan
Menopausal Hot Flashes Drugs Segment by Type
Pill Menopausal Hot Flashes Drugs
Oral Liquid Menopausal Hot Flashes Drugs
Other
Menopausal Hot Flashes Drugs Segment by Application
Retail Outlets
Online Stores
Menopausal Hot Flashes Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Menopausal Hot Flashes Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Menopausal Hot Flashes Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Menopausal Hot Flashes Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Menopausal Hot Flashes Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Menopausal Hot Flashes Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Menopausal Hot Flashes Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Menopausal Hot Flashes Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Pill Menopausal Hot Flashes Drugs
- Oral Liquid Menopausal Hot Flashes Drugs
- Other
Applications
- Retail Outlets
- Online Stores
Companies covered
- Novartis
- Pfizer
- Bayer
- Novo Nordisk
- iHealth Labs
- Hisamitsu Pharmaceutical
- Allergan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Menopausal Hot Flashes Drugs Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Menopausal Hot Flashes Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Menopausal Hot Flashes Drugs Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Menopausal Hot Flashes Drugs Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Menopausal Hot Flashes Drugs Market Dynamics
- 2.1 Menopausal Hot Flashes Drugs Industry Trends
- 2.2 Menopausal Hot Flashes Drugs Industry Drivers
- 2.3 Menopausal Hot Flashes Drugs Industry Opportunities and Challenges
- 2.4 Menopausal Hot Flashes Drugs Industry Restraints
3 Menopausal Hot Flashes Drugs Market by Manufacturers
- 3.1 Global Menopausal Hot Flashes Drugs Revenue by Manufacturers (2021-2026)
- 3.2 Global Menopausal Hot Flashes Drugs Sales by Manufacturers (2021-2026)
- 3.3 Global Menopausal Hot Flashes Drugs Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Menopausal Hot Flashes Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Menopausal Hot Flashes Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Menopausal Hot Flashes Drugs Manufacturers, Product Type & Application
- 3.7 Global Menopausal Hot Flashes Drugs Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Menopausal Hot Flashes Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Menopausal Hot Flashes Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Menopausal Hot Flashes Drugs Tier 1, Tier 2, and Tier 3
4 Menopausal Hot Flashes Drugs Market by Type
- 4.1 Menopausal Hot Flashes Drugs Type Introduction
- 4.1.1 Pill Menopausal Hot Flashes Drugs
- 4.1.2 Oral Liquid Menopausal Hot Flashes Drugs
- 4.1.3 Other
- 4.2 Global Menopausal Hot Flashes Drugs Sales by Type
- 4.2.1 Global Menopausal Hot Flashes Drugs Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Menopausal Hot Flashes Drugs Sales by Type (2021-2032)
- 4.2.3 Global Menopausal Hot Flashes Drugs Sales Market Share by Type (2021-2032)
- 4.3 Global Menopausal Hot Flashes Drugs Revenue by Type
- 4.3.1 Global Menopausal Hot Flashes Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Menopausal Hot Flashes Drugs Revenue by Type (2021-2032)
- 4.3.3 Global Menopausal Hot Flashes Drugs Revenue Market Share by Type (2021-2032)
5 Menopausal Hot Flashes Drugs Market by Application
- 5.1 Menopausal Hot Flashes Drugs Application Introduction
- 5.1.1 Retail Outlets
- 5.1.2 Online Stores
- 5.2 Global Menopausal Hot Flashes Drugs Sales by Application
- 5.2.1 Global Menopausal Hot Flashes Drugs Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Menopausal Hot Flashes Drugs Sales by Application (2021-2032)
- 5.2.3 Global Menopausal Hot Flashes Drugs Sales Market Share by Application (2021-2032)
- 5.3 Global Menopausal Hot Flashes Drugs Revenue by Application
- 5.3.1 Global Menopausal Hot Flashes Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Menopausal Hot Flashes Drugs Revenue by Application (2021-2032)
- 5.3.3 Global Menopausal Hot Flashes Drugs Revenue Market Share by Application (2021-2032)
6 Global Menopausal Hot Flashes Drugs Sales by Region
- 6.1 Global Menopausal Hot Flashes Drugs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Menopausal Hot Flashes Drugs Sales by Region (2021-2032)
- 6.2.1 Global Menopausal Hot Flashes Drugs Sales by Region (2021-2026)
- 6.2.2 Global Menopausal Hot Flashes Drugs Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Menopausal Hot Flashes Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Menopausal Hot Flashes Drugs Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Menopausal Hot Flashes Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Menopausal Hot Flashes Drugs Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Menopausal Hot Flashes Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Menopausal Hot Flashes Drugs Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Menopausal Hot Flashes Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Menopausal Hot Flashes Drugs Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Menopausal Hot Flashes Drugs Revenue by Region
- 7.1 Global Menopausal Hot Flashes Drugs Revenue by Region
- 7.1.1 Global Menopausal Hot Flashes Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Menopausal Hot Flashes Drugs Revenue by Region (2021-2026)
- 7.1.3 Global Menopausal Hot Flashes Drugs Revenue by Region (2027-2032)
- 7.1.4 Global Menopausal Hot Flashes Drugs Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Menopausal Hot Flashes Drugs Revenue (2021-2032)
- 7.2.2 North America Menopausal Hot Flashes Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Menopausal Hot Flashes Drugs Revenue (2021-2032)
- 7.3.2 Europe Menopausal Hot Flashes Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Menopausal Hot Flashes Drugs Revenue (2021-2032)
- 7.4.2 Asia-Pacific Menopausal Hot Flashes Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Menopausal Hot Flashes Drugs Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Menopausal Hot Flashes Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Novartis
- 8.1.1 Novartis Company Information
- 8.1.2 Novartis Business Overview
- 8.1.3 Novartis Menopausal Hot Flashes Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Novartis Menopausal Hot Flashes Drugs Product Portfolio
- 8.1.5 Novartis Recent Developments
- 8.2 Pfizer
- 8.2.1 Pfizer Company Information
- 8.2.2 Pfizer Business Overview
- 8.2.3 Pfizer Menopausal Hot Flashes Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Pfizer Menopausal Hot Flashes Drugs Product Portfolio
- 8.2.5 Pfizer Recent Developments
- 8.3 Bayer
- 8.3.1 Bayer Company Information
- 8.3.2 Bayer Business Overview
- 8.3.3 Bayer Menopausal Hot Flashes Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Bayer Menopausal Hot Flashes Drugs Product Portfolio
- 8.3.5 Bayer Recent Developments
- 8.4 Novo Nordisk
- 8.4.1 Novo Nordisk Company Information
- 8.4.2 Novo Nordisk Business Overview
- 8.4.3 Novo Nordisk Menopausal Hot Flashes Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Novo Nordisk Menopausal Hot Flashes Drugs Product Portfolio
- 8.4.5 Novo Nordisk Recent Developments
- 8.5 iHealth Labs
- 8.5.1 iHealth Labs Company Information
- 8.5.2 iHealth Labs Business Overview
- 8.5.3 iHealth Labs Menopausal Hot Flashes Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 iHealth Labs Menopausal Hot Flashes Drugs Product Portfolio
- 8.5.5 iHealth Labs Recent Developments
- 8.6 Hisamitsu Pharmaceutical
- 8.6.1 Hisamitsu Pharmaceutical Company Information
- 8.6.2 Hisamitsu Pharmaceutical Business Overview
- 8.6.3 Hisamitsu Pharmaceutical Menopausal Hot Flashes Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Hisamitsu Pharmaceutical Menopausal Hot Flashes Drugs Product Portfolio
- 8.6.5 Hisamitsu Pharmaceutical Recent Developments
- 8.7 Allergan
- 8.7.1 Allergan Company Information
- 8.7.2 Allergan Business Overview
- 8.7.3 Allergan Menopausal Hot Flashes Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Allergan Menopausal Hot Flashes Drugs Product Portfolio
- 8.7.5 Allergan Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Menopausal Hot Flashes Drugs Value Chain Analysis
- 9.1.1 Menopausal Hot Flashes Drugs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Menopausal Hot Flashes Drugs Production Mode & Process
- 9.2 Menopausal Hot Flashes Drugs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Menopausal Hot Flashes Drugs Distributors
- 9.2.3 Menopausal Hot Flashes Drugs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst